Stock 3034 QOL HOLDINGS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Qol Holdings Co., Ltd.

Equities

3034

JP3266160005

Drug Retailers

Delayed Japan Exchange
Other stock markets
 11:30:00 27/06/2024 am IST 		5-day change 1st Jan Change
1,507 JPY +0.53% Intraday chart for Qol Holdings Co., Ltd. +4.29% -9.05%
30/05 Qol Holdings Co., Ltd. agreed to acquire Bottom Heart Co., Ltd./Gyotoku Pharmacy Co., Ltd. CI
16/05 Qol Holdings Co., Ltd. acquired Dyna Co., Ltd. CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 57,947 49,905 58,665 42,853 42,933 55,946 - -
Enterprise Value (EV) 1 66,600 66,753 68,738 49,450 46,913 70,242 82,475 84,967
P/E ratio 14.8 x 12.4 x 17.4 x 7.81 x 7.59 x 13.5 x 6.9 x 4.58 x
Yield 1.86% 2.11% 1.8% 2.4% 2.76% 1.7% 2.67% 3.34%
Capitalization / Revenue 0.4 x 0.3 x 0.36 x 0.26 x 0.25 x 0.37 x 0.21 x 0.2 x
EV / Revenue 0.46 x 0.4 x 0.42 x 0.3 x 0.28 x 0.39 x 0.31 x 0.3 x
EV / EBITDA 5.96 x 5.4 x 5.71 x 3.39 x 3.26 x 5.18 x 3.08 x 3.02 x
EV / FCF -2,64,91,771 x -60,96,739 x 69,80,628 x 70,39,084 x 1,67,42,579 x 82,62,762 x -40,25,124 x 72,17,089 x
FCF Yield -0% -0% 0% 0% 0% 0% -0% 0%
Price to Book 1.5 x 1.23 x 1.38 x 0.98 x 0.88 x 1.25 x 0.94 x 0.8 x
Nbr of stocks (in thousands) 38,427 37,664 37,703 36,720 36,979 37,322 - -
Reference price 2 1,508 1,325 1,556 1,167 1,161 1,499 1,499 1,499
Announcement Date 15/05/19 29/05/20 14/05/21 13/05/22 11/05/23 10/05/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,44,783 1,65,411 1,61,830 1,66,199 1,70,036 1,80,052 2,70,000 2,82,000
EBITDA 1 11,167 12,352 12,033 14,588 14,379 13,565 26,800 28,100
EBIT 1 7,050 7,733 7,360 9,855 9,495 8,324 19,000 20,000
Operating Margin 4.87% 4.68% 4.55% 5.93% 5.58% 4.62% 7.04% 7.09%
Earnings before Tax (EBT) 1 7,165 7,683 6,895 9,687 9,584 8,860 18,500 19,500
Net income 1 3,908 4,067 3,370 5,489 5,656 4,880 8,100 12,200
Net margin 2.7% 2.46% 2.08% 3.3% 3.33% 2.71% 3% 4.33%
EPS 2 101.7 107.2 89.55 149.5 153.0 131.1 217.2 327.2
Free Cash Flow -2,514 -10,949 9,847 7,025 2,802 8,501 -20,490 11,773
FCF margin -1.74% -6.62% 6.08% 4.23% 1.65% 4.72% -7.59% 4.17%
FCF Conversion (EBITDA) - - 81.83% 48.16% 19.49% 62.67% - 41.9%
FCF Conversion (Net income) - - 292.2% 127.98% 49.54% 174.2% - 96.5%
Dividend per Share 2 28.00 28.00 28.00 28.00 32.00 30.00 40.00 50.00
Announcement Date 15/05/19 29/05/20 14/05/21 13/05/22 11/05/23 10/05/24 - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4
Net sales 1 81,249 79,090 41,464 81,814 42,731 41,654 40,550 41,909 82,459 43,642 43,935 43,403 45,137 88,540 45,988 45,524
EBITDA - - - - - - - - - - - - - - - -
EBIT 1 3,432 2,080 2,350 4,177 2,744 2,934 1,658 2,364 4,022 2,819 2,654 1,873 1,686 3,559 2,170 2,595
Operating Margin 4.22% 2.63% 5.67% 5.11% 6.42% 7.04% 4.09% 5.64% 4.88% 6.46% 6.04% 4.32% 3.74% 4.02% 4.72% 5.7%
Earnings before Tax (EBT) 3,618 1,886 - 4,280 2,777 - 1,755 - 4,156 2,912 - 1,923 - 3,612 2,912 -
Net income 1 1,830 630 1,422 2,455 1,700 1,334 1,001 1,365 2,366 1,792 1,498 1,010 878 1,888 1,886 1,106
Net margin 2.25% 0.8% 3.43% 3% 3.98% 3.2% 2.47% 3.26% 2.87% 4.11% 3.41% 2.33% 1.95% 2.13% 4.1% 2.43%
EPS 47.90 16.75 - 66.98 46.28 - 27.18 - 64.11 48.46 - 27.22 - 50.80 50.67 -
Dividend per Share 14.00 14.00 - 14.00 - - - - 15.00 - - - - 15.00 - -
Announcement Date 06/11/19 29/10/20 05/11/21 05/11/21 04/02/22 13/05/22 05/08/22 04/11/22 04/11/22 03/02/23 11/05/23 04/08/23 02/11/23 02/11/23 02/02/24 10/05/24
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 8,653 16,848 10,073 6,597 3,980 4,350 26,529 29,021
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 0.7749 x 1.364 x 0.8371 x 0.4522 x 0.2768 x 0.3207 x 0.9899 x 1.033 x
Free Cash Flow -2,514 -10,949 9,847 7,025 2,802 8,501 -20,490 11,773
ROE (net income / shareholders' equity) 10.5% 10.3% 8.2% 12.9% 12.2% 9.6% 14.4% 18.8%
ROA (Net income/ Total Assets) 7.94% 8.14% 7.28% 10.3% 10.2% 8.43% 13.5% 11.9%
Assets 1 49,216 49,953 46,306 53,442 55,420 57,912 60,000 1,02,521
Book Value Per Share 2 1,007 1,075 1,124 1,190 1,315 1,414 1,598 1,875
Cash Flow per Share 146.0 151.0 132.0 192.0 198.0 181.0 - -
Capex 1 6,241 15,417 3,374 3,426 4,510 5,032 4,000 4,000
Capex / Sales 4.31% 9.32% 2.08% 2.06% 2.65% 2.79% 1.48% 1.42%
Announcement Date 15/05/19 29/05/20 14/05/21 13/05/22 11/05/23 10/05/24 - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Qol Holdings Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Retail - Drugs without Grocery

1st Jan change Capi.
QOL HOLDINGS CO., LTD. Stock Qol Holdings Co., Ltd.
-9.05% 348M
RAIA DROGASIL S.A. Stock Raia Drogasil S.A.
-10.17% 8.23B
AIN HOLDINGS INC. Stock Ain Holdings Inc.
+39.05% 1.37B
NIHON CHOUZAI CO.,LTD. Stock NIHON CHOUZAI Co.,Ltd.
+6.93% 276M
SALUS, LJUBLJANA, D. D. Stock SALUS, Ljubljana, d. d.
+9.44% 222M
PETMED EXPRESS, INC. Stock PetMed Express, Inc.
-46.30% 80.81M
GREEN CROSS HEALTH LIMITED Stock Green Cross Health Limited
-32.11% 64.62M
MEDICAL IKKOU GROUP CO.,LTD. Stock Medical Ikkou Group Co.,Ltd.
+26.51% 61.74M
Retail - Drugs without Grocery
  1. Stock Market
  2. Equities
  3. 3034 Stock
  4. Financials Qol Holdings Co., Ltd.